Latest Rafarma Pharmaceuticals Inc. Stories
MOSCOW, April 10, 2014 /PRNewswire/ -- In response to shareholder inquiries, CEO Dave Anderson offers further comment on the improved financial position of Rafarma: "Due to the overwhelming
MOSCOW, Feb. 5, 2014 /PRNewswire/ -- On February 3, 2014, ZAO Rafarma management met with senior faculty members of the St.
MOSCOW, Jan. 28, 2014 /PRNewswire/ -- Rafarma Pharmaceuticals (OTC:RAFA) and St. Petersburg-based Pharmsynthez have opened discussions for Joint Venture Production.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.